- Home
- DERM vs NAGE Comparison
DERM vs NAGE Comparison
Compare DERM & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DERM | NAGE |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.3M | 212.8M |
| IPO Year | 2021 | 2010 |
Fundamental Metrics
Financial Performance| Metric | DERM | NAGE |
|---|---|---|
| Price | $4.30 | $2.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $13.75 | $11.92 |
| AVG Volume (30 Days) | 193.9K | ★ 481.7K |
| Earning Date | 11-16-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 34.72 | ★ 81.82 |
| EPS | N/A | ★ 0.07 |
| Revenue | $61,858,000.00 | ★ $129,423,000.00 |
| Revenue This Year | $25.29 | N/A |
| Revenue Next Year | $50.00 | $16.92 |
| P/E Ratio | ★ N/A | $28.00 |
| Revenue Growth | 10.20 | ★ 29.95 |
| 52 Week Low | $4.31 | $2.31 |
| 52 Week High | $9.56 | $7.28 |
Technical Indicators
Market Signals| Indicator | DERM | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 36.54 | 45.63 |
| Support Level | $4.31 | N/A |
| Resistance Level | $5.50 | $3.61 |
| Average True Range (ATR) | 0.33 | 0.10 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 18.50 | 75.00 |
Price Performance
Historical ComparisonAbout DERM Journey Medical Corporation
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
About NAGE Niagen Bioscience Inc.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.